Diabetic autonomic neuropathy in BB rats and effect of ARI treatment on heart-rate variability and vagus nerve structure.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model study (spontaneously diabetic BB rats)
PubMed 2110085 · doi:10.2337/diab.39.5.613
What was done
Researchers evaluated the preventive effect of the aldose reductase inhibitor ponalrestat on heart-rate variability and vagus nerve structural changes over 4 to 6 months in spontaneously diabetic BB rats.
What was found
Ponalrestat completely prevented the decrease in heart-rate variability and axonal atrophy of the vagus nerve for 4 months in hyperglycemic rats. At 6 months, the preventive effect on heart-rate variability was partial, and the vagus nerve showed an increase in regenerating myelinated and unmyelinated fibers. The abstract provides no exact numerical values, sample sizes, or statistical metrics.
Why it matters
It demonstrates in an animal model that diabetic vagus nerve autonomic neuropathy is linked to the polyol pathway and can be delayed by aldose reductase inhibition independently of glycemic control.
Limits
The study was conducted in rodents, so findings cannot be directly applied to human diabetic autonomic neuropathy. The abstract omits sample sizes, drug dosages, control group details, and quantitative data.
Cited by
- supports Sustained high blood sugars cause vagus nerve damage in individuals with diabetes.